TWiV 1018: Clinical update with Dr. Daniel Griffin
b'
In his weekly clinical update, Dr. Griffin discusses the CDC vaccine advisory group recommending the newly approved RSV vaccines, association of culturable-virus detection and household transmission of SARS-CoV-2, prevention of COVID-19 following a single intramuscular administration of Adintrevimab, real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19, and COVID-19 convalescent plasma outpatient therapy to prevent outpatient hospitalization.
Subscribe (free):\\xa0Apple Podcasts,\\xa0Google Podcasts,\\xa0RSS,\\xa0email
Become a\\xa0patron\\xa0of\\xa0TWiV!
Links for this episode
- CDC vaccine advisory group\\xa0recommends\\xa0RSV vaccines
- Association\\xa0of culturable-virus detection and household transmission of SARS-CoV-2 (JID)
- Prevention of COVID-19 following\\xa0intramuscular administration\\xa0of Adintrevimab (OFID)
- Real-world effectiveness\\xa0of Nirmatrelvir/Ritonavir on COVID-19 (CID)
- COVID-19 convalescent plasma outpatient therapy to\\xa0prevent hospitalization\\xa0(CID)
- Contribute to our\\xa0FIMRC fundraiser at PWB
- Letters read\\xa0on TWiV 1018
- Dr. Griffin\\u2019s COVID treatment summary (pdf)
- Timestamps by\\xa0Jolene. Thanks!
Intro music is by\\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
'